KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Income from Continuing Operations (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Income from Continuing Operations for 9 consecutive years, with 276000000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 3350.0% to 276000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 232000000.0 through Dec 2025, down 168.64% year-over-year, with the annual reading at 232000000.0 for FY2025, 168.64% down from the prior year.
  • Income from Continuing Operations hit 276000000.0 in Q4 2025 for Elanco Animal Health, down from 34000000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 364000000.0 in Q3 2024 to a low of 1096000000.0 in Q3 2023.
  • Historically, Income from Continuing Operations has averaged 86050000.0 across 5 years, with a median of 57000000.0 in 2021.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 179.69% in 2022 and later crashed 3350.0% in 2025.
  • Year by year, Income from Continuing Operations stood at 105000000.0 in 2021, then increased by 15.24% to 89000000.0 in 2022, then crashed by 58.43% to 141000000.0 in 2023, then soared by 94.33% to 8000000.0 in 2024, then plummeted by 3350.0% to 276000000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for ELAN at 276000000.0 in Q4 2025, 34000000.0 in Q3 2025, and 11000000.0 in Q2 2025.